GAO Skeptical About Benefits Of Medicare Anti-Fraud "Specialist" Contract
This article was originally published in The Gray Sheet
The Health Care Financing Administration's Medicare anti-fraud "specialist" program may not yield the "important benefits [anticipated] when the Health Insurance Portability and Accountability Act gave HCFA this contracting authority," the General Accounting Office advises in a June 1 report.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.